Phase II Trial Of Intravesical Gemcitabine And MK-3475 (Pembrolizumab) In The Treatment Of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Read more
A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study To Compare Tivozanib In Combination With Nivolumab To Tivozanib In Subjects With Renal Cell Carcinoma Who Have Progressed Following One Or Two Lines Of Therapy, One Of Which Is An Immune Checkpoint Inhibitor Read more
A Phase II/III Trial Of MEDI4736 (Durvalumab) And Chemotherapy For Patients With High Grade Upper Tract Urothelial Cancer Prior To Nephroureterectomy Read more
A Phase 3, Randomized, Double-Blind Study Of Pembrolizumab Versus Placebo In Combination With Paclitaxel With Or Without Bevacizumab For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer (KEYNOTE-B96 / ENGOT-Ov65) Read more
An Open-Label, Phase 1, First-In-Human, Dose Escalation And Expansion Study To Evaluate The Safety, Tolerability, Maximum Tolerated Or Administered Dose, Pharmacokinetics, Pharmacodynamics And Tumor Response Profile Of The ILDR2 Function-Blocking Antibody BAY 1905254 In Patients With Advanced Solid Tumors (18789) Read more
A Phase Ib/Ii, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Treatment Combinations In Patients With Breast Cancer (Morpheus-Breast Cancer) Read more
OASIS: Phase II Trial Of Oral SM-88 In Patients With Metastatic Hormone Receptor-Positive HER2-Negative (HR+/HER2-) Breast Cancer. Read more
